Article
The evolving molecular genetic landscape in acute myeloid leukaemia.
Current opinion in hematology - 1 Mar 2013
Sanders Mathijs A, Valk Peter J M
Abstract excerpt
PURPOSE OF REVIEW: Acute myeloid leukaemia (AML) is a heterogeneous disease with a variable response to therapy. The heterogeneity of AML is evident from variations in morphology, immunophenotype, cytogenetics and molecular abnormalities. The introduction of genome-wide technologies has enabled an even more detailed molecular analysis of AML. As a result, the molecular landscape of AML is rapidly evolving. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
